ACETAMINOPHEN, ASPIRIN AND CAFFEINE
Clinical safety rating: avoid
Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.
Acetaminophen: weak COX-1/2 inhibitor, analgesic and antipyretic through central action; Aspirin: irreversible COX-1/2 inhibitor, anti-inflammatory, analgesic, antipyretic, antiplatelet; Caffeine: adenosine receptor antagonist, CNS stimulant, enhances analgesic effect.
| Metabolism | Acetaminophen: primarily hepatic via glucuronidation (UGT1A1, UGT1A6, UGT1A9), sulfation (SULT1A1), and minor CYP2E1 (toxic metabolite NAPQI); Aspirin: hydrolyzed to salicylate, further metabolized by conjugation (glycine, glucuronic acid) and oxidation; Caffeine: hepatic via CYP1A2 (major), CYP2E1, CYP3A4, N-acetyltransferase. |
| Excretion | Acetaminophen: renal elimination of metabolites (glucuronide 60%, sulfate 30%, cysteine/mercapturate 8%, unchanged 2%); aspirin: renal elimination of salicylate and metabolites (75% salicyluric acid, 10% glucuronides, 10% salicylate); caffeine: renal elimination of metabolites (paraxanthine, theobromine, theophylline; <3% unchanged). Total: >95% renal. |
| Half-life | Acetaminophen: 2-4 hours (prolonged in liver disease); aspirin: 15-20 minutes (active metabolite salicylate: 2-3 hours at low doses, prolonged to 15-30 hours at high doses); caffeine: 3-6 hours (prolonged in pregnancy, liver disease). |
| Protein binding | Acetaminophen: 10-25% (albumin); aspirin: 80-90% (albumin, decreased at high doses); caffeine: 35% (albumin). |
| Volume of Distribution | Acetaminophen: 0.9-1.0 L/kg; aspirin: 0.15-0.2 L/kg (low); caffeine: 0.6-0.8 L/kg. Reflects distribution into total body water. |
| Bioavailability | Acetaminophen: oral 85-98%; aspirin: oral 50-80% (due to first-pass hydrolysis); caffeine: oral ~100%. |
| Onset of Action | Oral: acetaminophen 30-60 min; aspirin 30-60 min; caffeine 30-60 min. Peak effects at 1-2 hours. |
| Duration of Action | Acetaminophen: 4-6 hours; aspirin: 4-6 hours (antiplatelet effect 7-10 days due to irreversible COX-1 inhibition); caffeine: 4-6 hours (1-2 hours to peak, duration 3-5 hours). |
| Molecular Weight | 180.16 |
1-2 tablets (250 mg acetaminophen, 250 mg aspirin, 65 mg caffeine per tablet) orally every 4-6 hours as needed for pain or fever; maximum 8 tablets per 24 hours.
| Dosage form | TABLET |
| Renal impairment | Contraindicated in severe renal impairment (CrCl <10 mL/min). For CrCl 10-50 mL/min: avoid aspirin component; consider alternative therapy. For CrCl >50 mL/min: no adjustment needed for acetaminophen; aspirin may require dose reduction or monitoring. |
| Liver impairment | Child-Pugh A: caution with acetaminophen (max 2 g/day) and avoid caffeine if severe. Child-Pugh B: avoid aspirin; reduce acetaminophen dose (max 2 g/day) and limit caffeine. Child-Pugh C: contraindicated due to aspirin and acetaminophen risk. |
| Pediatric use | Not recommended for children <12 years due to aspirin risk of Reye's syndrome. For adolescents ≥12 years: same as adult dosing: 1-2 tablets every 4-6 hours, max 8 tablets/24 hours. |
| Geriatric use | Caution due to increased sensitivity to aspirin (GI bleeding, renal impairment) and caffeine (insomnia, tachycardia). Start at low end of dosing: 1 tablet every 6 hours; monitor renal function and avoid long-term use. |
| 1st trimester | Aspirin is generally avoided due to risk of teratogenicity; acetaminophen and caffeine are considered safer in low doses, but combination product should be used cautiously. Acetaminophen crosses placenta and has minimal risk, but high doses may be harmful. Aspirin is linked to increased risk of gastroschisis and other malformations. Caffeine in moderate amounts appears safe, but high intake may increase miscarriage risk. |
| 2nd trimester | Aspirin should be avoided unless prescribed for specific conditions (e.g., preeclampsia prophylaxis). Acetaminophen and caffeine are relatively safe, but combination product should be used only if clearly needed. Chronic high-dose aspirin can affect fetal renal function. |
| 3rd trimester | Aspirin is contraindicated during third trimester due to risk of premature closure of ductus arteriosus and maternal/fetal bleeding complications. Acetaminophen and caffeine may be used cautiously, but caffeine high intake may cause neonatal withdrawal symptoms. |
Clinical note
Anticoagulants like warfarin increase bleeding risk Concomitant use with other NSAIDs increases GI toxicity Risk of Reye's syndrome in children and teenagers with viral infections.
| FDA category | Positive |
■ FDA Black Box Warning
Reye syndrome warning: Aspirin should not be used in children or teenagers with viral illnesses due to risk of Reye syndrome.
| Common Effects | fever |
| Serious Effects |
Third trimester of pregnancyActive peptic ulcer diseaseHemophilia or other bleeding disordersSevere hepatic impairmentHypersensitivity to any componentConcomitant use of methotrexate at doses >15 mg/weekChildren and teenagers with viral illness (Reye's syndrome risk with aspirin)
| Precautions | Hepatotoxicity (acetaminophen overdose), gastrointestinal bleeding (aspirin), Reye syndrome (aspirin in children with viral illness), cardiovascular risk (aspirin may increase bleeding), caffeine-related CNS stimulation, risk of dependence. |
| Food/Dietary | Alcohol increases risk of hepatotoxicity with acetaminophen and GI bleeding with aspirin. Caffeine-containing foods or beverages should be limited to avoid excessive caffeine intake. High-tyramine foods (e.g., aged cheeses, cured meats) may potentiate caffeine effects; no significant interaction documented. |
Loading safety data…
| Placental transfer | All three components cross the placenta: Acetaminophen crosses readily, aspirin crosses and is metabolized to salicylate which also crosses, and caffeine crosses rapidly. Degree of transfer is significant for all. |
| Breastfeeding | Acetaminophen, aspirin, and caffeine are excreted into breast milk. Acetaminophen is considered safe at therapeutic doses. Aspirin is excreted in small amounts, but repeated high doses may cause adverse effects in the infant (e.g., Reye's syndrome, bleeding). Caffeine passes into milk and may cause irritability or poor sleep in infants. Use of combination product should be minimized; avoid high-dose aspirin and limit caffeine intake. Monitor infant for signs of side effects. |
| Lactation Rating | L3: Moderately Safe (aspirin and caffeine may be of concern in high doses; acetaminophen is safer) |
| Teratogenic Risk | First trimester: Aspirin is associated with increased risk of neural tube defects and cardiac malformations; acetaminophen is considered low risk but some studies suggest possible association with gastroschisis. Second trimester: Aspirin may increase risk of intracranial hemorrhage; acetaminophen and caffeine generally not linked to major malformations. Third trimester: Aspirin use is contraindicated due to risk of premature ductus arteriosus closure and oligohydramnios; high-dose acetaminophen may cause oligohydramnios; caffeine metabolism slows, but moderate intake appears safe; chronic high-dose caffeine may be associated with low birth weight. |
| Fetal Monitoring | Monitor fetal growth and amniotic fluid volume via ultrasound, especially with high-dose aspirin. Monitor for bleeding complications (maternal and fetal). Assess renal function in mother and fetus if high-dose aspirin. For caffeine, monitor maternal heart rate and blood pressure; fetal heart rate tracings may show changes. |
| Fertility Effects | Aspirin: Low-dose may improve pregnancy rates in women with thrombophilia or antiphospholipid syndrome; high doses may interfere with ovulation. Acetaminophen: Some studies suggest possible delay in time to pregnancy; effect on male fertility unclear. Caffeine: High intake (>500 mg/day) may reduce fertility; moderate intake not consistently associated. |
| Clinical Pearls | Acetaminophen, aspirin, and caffeine combination is used for mild to moderate pain and fever reduction. Aspirin component provides anti-inflammatory effects; caution in patients with bleeding disorders or those on anticoagulants due to increased bleeding risk. Acetaminophen hepatotoxicity risk with doses >4g/day or in liver disease. Caffeine may cause insomnia, tremor, or palpitations; avoid in patients with anxiety disorders. Reye syndrome risk with aspirin use in children with viral illnesses. Monitor renal function in elderly or dehydrated patients. |
| Patient Advice | Do not exceed recommended dose; acetaminophen overdose can cause liver damage. · Avoid alcohol while taking this medication. · Do not use in children or teenagers with viral illnesses due to Reye syndrome risk. · May cause stomach upset; take with food or milk. · Limit caffeine intake from other sources when using this medication. |